SE8701765D0 - ANALYSIS METHOD AND MEANS THEREFOR - Google Patents

ANALYSIS METHOD AND MEANS THEREFOR

Info

Publication number
SE8701765D0
SE8701765D0 SE8701765A SE8701765A SE8701765D0 SE 8701765 D0 SE8701765 D0 SE 8701765D0 SE 8701765 A SE8701765 A SE 8701765A SE 8701765 A SE8701765 A SE 8701765A SE 8701765 D0 SE8701765 D0 SE 8701765D0
Authority
SE
Sweden
Prior art keywords
virus
disclosed
analysis method
means therefor
related human
Prior art date
Application number
SE8701765A
Other languages
Swedish (sv)
Other versions
SE8701765L (en
Original Assignee
Statens Bakteriologiska Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Bakteriologiska Lab filed Critical Statens Bakteriologiska Lab
Priority to SE8701765A priority Critical patent/SE8701765L/en
Publication of SE8701765D0 publication Critical patent/SE8701765D0/en
Priority to AU17110/88A priority patent/AU1711088A/en
Priority to PCT/SE1988/000218 priority patent/WO1988008449A1/en
Publication of SE8701765L publication Critical patent/SE8701765L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention pertains to the isolation of a HIV related human retrovirus with antigenic similarities with HTLV-IV and LAV-II. The entire genome of the virus is disclosed. A method for large scale production of this virus and of viral antigens and a method for detection of antibodies directed against HIV related human retroviruses, as well as identification of viral antigenes which can be used for production of polyclonal and monoclonal antibodies and active immunisation, are disclosed.
SE8701765A 1987-04-28 1987-04-28 METHOD OF ANALYSIS AND AGENTS FOR THIS SE8701765L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (en) 1987-04-28 1987-04-28 METHOD OF ANALYSIS AND AGENTS FOR THIS
AU17110/88A AU1711088A (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof
PCT/SE1988/000218 WO1988008449A1 (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (en) 1987-04-28 1987-04-28 METHOD OF ANALYSIS AND AGENTS FOR THIS

Publications (2)

Publication Number Publication Date
SE8701765D0 true SE8701765D0 (en) 1987-04-28
SE8701765L SE8701765L (en) 1988-10-29

Family

ID=20368350

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701765A SE8701765L (en) 1987-04-28 1987-04-28 METHOD OF ANALYSIS AND AGENTS FOR THIS

Country Status (3)

Country Link
AU (1) AU1711088A (en)
SE (1) SE8701765L (en)
WO (1) WO1988008449A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE120234T1 (en) * 1988-06-09 1995-04-15 Innogenetics Nv HIV-3 RETROVIRUS AND ITS USE.
US5223423A (en) * 1989-03-31 1993-06-29 United States Of America Characterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isy
DE68925202T2 (en) * 1989-05-31 1996-06-05 Pasteur Institut HIV-2 EHO retrovirus proteins and glycoproteins, antibodies against them, use for diagnostic purposes
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
CH675636A5 (en) * 1985-01-15 1990-10-15 Cancer Res Inst
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0239425B1 (en) * 1986-01-22 1989-11-02 Institut Pasteur Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses

Also Published As

Publication number Publication date
AU1711088A (en) 1988-12-02
SE8701765L (en) 1988-10-29
WO1988008449A1 (en) 1988-11-03

Similar Documents

Publication Publication Date Title
SE8604007D0 (en) VACCIN AND IMMUNO ANALYSIS FOR PREVENTED IMMUNO CANCEL SYNDROME (AIDS)
NO169844C (en) HTLV-III (ENV) Peptides
BR9305435A (en) Process for determining peptides corresponding to immunologically important epitopes and their use in a process for determining biotinylated antibodies or peptides corresponding to immunologically important epitopes, process for preparing them and compositions containing them
PT584348E (en) GENETIC VACCINE FOR IMMUNODEFICIENCY VIRUS
EA200300336A1 (en) HIV PEPTIDES, ANTIGENES, VACCINE COMPOSITIONS, KIT FOR IMMUNO ANALYSIS AND METHOD OF DETECTING ANTIBODIES INDUCED BY HIV
ES2066887T3 (en) MONOCLONAL ANTIBODY TO DIFFERENT HIV-2 SEROPOSITIVE INDIVIDUALS FROM HIV-1.
DE3855134D1 (en) MONOCLONAL HUMAN ANTIBODIES AGAINST HIV-I
ES553757A0 (en) A METHOD FOR PREPARING PROTEINS THAT ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES FOR VIRUSES ASSOCIATED WITH LYMPHADENOPATHY
SE8701765D0 (en) ANALYSIS METHOD AND MEANS THEREFOR
Falkler Jr et al. Human antibody to dengue soluble complement-fixing (SCF) antigens
Pedersen Jr et al. Separation, isolation, and immunological studies of the structural proteins of Venezuelan equine encephalomyelitis virus
ES2071626T3 (en) MONOCLONAL ANTIBODY OF THE MOUSE AGAINST THE PROTEIN GP41 OF THE VIRUSES OF HUMAN IMMUNODEFICIENCY.
ES2056075T3 (en) MONOCLONAL ANTIBODIES FOR SPECIFIC ANTIGENIC REGIONS OF HUMAN IMMUNODEFICIENCY VIRUSES AND PROCEDURES FOR ITS USE.
FI95871B (en) A method for producing an HIV particulate immunogen and an antibody thereto
DE3855280D1 (en) ANTIGENT RECOGNIZED BY MCA 16-88
DK0537168T3 (en) The antigen CTAA 28A32, which is recognized by MCA 28A32
KR890008318A (en) Recombinant histidine-containing protein of Plasmodium falciparum, preparation method and use thereof
ATE134649T1 (en) DRUGS AND METHODS FOR TREATING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX USING CARBOHYDRATE-SPECIFIC ANTIBODIES
UA8704A1 (en) Method for determibation of antigenic novelty of influenza virus
DK340887D0 (en) ANTIGENIC PEPTID ISOLATED FROM 28 KD PROTEIN PHRASES. MANSONI AND PROCEDURE FOR ITS INSULATION, MONOCLONAL ANTIBODIES, RECOGNIZING AT LEAST ONE EPITOPE OF THE PEPTID AND ITS USE FOR THE SYNTHESIS OF ANTIBODIES
LIU et al. Preparation of refined antimeasles gamma globulin from immunized goats and pigs
DE3475309D1 (en) Synthetic peptide, immune globulin and process for immunizing a mammal

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701765-3

Effective date: 19901101

Format of ref document f/p: F